| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Calcium — Calcium is an essential divalent cation and ubiquitous second messenger that supports membrane excitability, secretion, coagulation, contraction, mitochondrial function, and cell-fate signaling. In oncology, its relevance is primarily as a tightly homeostatically controlled signaling ion rather than a conventional anticancer drug. Formal classification: essential mineral; electrolyte; signaling ion; nutrient/supplement, with a separate locoregional interventional use in calcium electroporation (typically intratumoral calcium chloride plus electric pulses). Standard abbreviation: Ca; biologically active species: Ca2+. Most body calcium is stored in bone, while the small ionized extracellular pool mediates signaling; this tight systemic regulation is a major translational constraint because oral or routine supplemental calcium does not usually generate tumoricidal intracellular calcium overload. The clearest direct anticancer deployment is local calcium electroporation, whereas broader anticancer effects from dietary or supplemental calcium remain context-dependent and are strongest for colorectal-risk associations rather than established systemic therapy. Primary mechanisms (ranked):
Bioavailability / PK relevance: Oral calcium is absorbed by active vitamin-D-dependent transport and passive diffusion; fractional absorption falls as dose rises. Serum total calcium and ionized calcium are kept within narrow ranges by intestinal absorption, bone buffering, and renal handling, so systemic exposure is tightly clamped. Supplement form matters: calcium carbonate is acid/meal dependent, while calcium citrate is less so. For direct anticancer use, delivery is the main issue: local intratumoral calcium plus electroporation can create abrupt intracellular overload, whereas standard oral supplementation generally cannot. In-vitro vs systemic exposure relevance: This is a major limitation. Many in-vitro anticancer experiments use extracellular calcium conditions or electroporation-enabled intracellular loading that exceed what can be achieved safely through ordinary dietary or supplement use. Physiologic ionized serum calcium is only about 1.15–1.33 mmol/L, and homeostasis strongly resists sustained elevation. Thus, concentration-driven tumor kill is generally not achievable systemically without toxicity; calcium electroporation is the main exception because it bypasses the membrane barrier locally. Clinical evidence status: Systemic calcium supplementation: no established direct anticancer treatment role; evidence is mainly observational or chemopreventive, strongest for colorectal-risk reduction signals but not sufficient to regard calcium as a validated systemic anticancer therapy. Calcium electroporation: small human studies, including phase I/II and randomized comparisons versus electrochemotherapy for cutaneous/subcutaneous lesions, support feasibility, local response activity, and generally favorable tolerability, but this remains a niche locoregional approach rather than standard broad oncology care. Mechanistic profile
P: 0–30 min R: 30 min–3 hr G: >3 hr |
| Source: |
| Type: |
| Refering to the undesired side effects of treatments such as Chemotherapy. |
| 774- | Mg, | Calc, | Chemo, | Dietary Intake of Magnesium or Calcium and Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Patients |
| - | Analysis, | NA, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:244 Target#:784 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid